Schedule 13G ownership disclosure

UNICYCIVE THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 90466Y103

Event date: 2024-12-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nantahala Capital Management, LLC

    Shares: 10,879,142.00 · Class: 9.99%

  • Wilmot B. Harkey

    Shares: 10,879,142.00 · Class: 9.99%

  • Daniel Mack

    Shares: 10,879,142.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-130851
Form type
SCHEDULE 13G/A
Filer
Nantahala Capital Management, LLC
CIK
CIK 1472322
Filed
Dec 20, 2024
Reporting period
Dec 19, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub